Seattle institute shares favorable results for malaria vaccine

06/30/2009 | Seattle Times, The

Researchers at Seattle Biomedical Research Institute have successfully engineered the genes of malaria-carrying parasites and used these to create an experimental vaccine that proved 100% effective in tests on rats and mice. The researchers plan to test the vaccine candidate on humans next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL